The 2023 Annual Meeting will feature a keynote presentation and three panel sessions.

• Changing Lives with Gene Therapies
  • Emily Chee, U.S. general manager, Novartis Gene Therapies
• Federal Update
  • Andrew Barnhill, head of public policy, IQVIA (moderator)
  • ​Aiken Hackett, vice president, federal government relations, BIO
  • Christine Harhaj, senior director, advocacy and strategic alliances, PhRMA 
  • Andrew Harker, principal, The Russell Group
  • Roxy Kozyckyj, director of state government and regional affairs, AdvaMed
  • Sophia McLeod, director of government relations, ACRO
• Navigating Regulatory Hurdles in Pharma and Food
  • ​Randy Deinhammer, director of regulatory affairs, Novozymes 
  • Eliza Deriso, director, quality services, Azzur Group (moderator)
  • Dan Jenkins, vice president, regulatory and government affairs, Pairwise
  • David Jensen, senior regulatory affairs scientist, Office of Regulatory Affairs and Quality, Duke University School of Medicine
  • ​Zohra Lomri, executive director of regulatory affairs, Syneos Health
• The Customer’s Journey
  • Rep. Becky Carney, co-chair, Justus-Warren Heart Disease and Stroke Prevention Task Force
  • Chandler Conley, patient, type I diabetes
  • Mapillar Dahn, founder and chief executive officer, MTS Sickle Cell Foundation
  • Abby Jones, patient advocate, spinal muscular atrophy type II
  • ​Peg O’Connell, chair, Care4Carolina (moderator)

There will also be opportunities to network during the break(s) and lunch.